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Abstract
Background
A link between angina with no obstructive coronary artery disease (CAD) and heart failure
with preserved left ventricular ejection fraction has been proposed, but evidence in support
of this is lacking. In a cross-sectional study, we investigated whether left ventricular diastolic
function in women with angina pectoris and no obstructive CAD differed from a reference
population.
Methods
We included 956 women with angina and <50% coronary artery stenosis at invasive coro-
nary angiography. Women with cardiovascular risk factors, but no history of chest pain or
cardiac disease served as controls (n = 214). Left ventricular diastolic function was
assessed by transthoracic echocardiography.
Results
The women with angina were slightly older, had higher body mass index, higher heart rate,
and more had diabetes compared with controls while systolic blood pressure was lower. In
age-adjusted analyses, angina patients had significantly lower E/A (Estimated difference
-0.13, 95% CI: -0.17; -0.08), higher left ventricular mass index (5.73 g/m2, 95% CI: 3.71;
7.75), left atrial volume index (2.34 ml/m2, 95% CI: 1.23; 3.45) and E/e’ (0.68, 95% CI: 0.30;
1.05) and a larger proportion had higher estimated left ventricular filling pressure (17% ver-
sus 6%, p = 0.001). No between group differences were seen for e’ or deceleration time.
After adjustment for known cardiovascular risk factors, between group differences for echo-
cardiographic parameters remained statistically significant.
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Conclusions
Patients with angina and no obstructive CAD had a more impaired left ventricular diastolic
function compared with an asymptomatic reference population. This suggests some com-
mon pathophysiological pathway between the two syndromes.
Introduction
Women with chest pain suggestive of angina pectoris often undergo multiple examinations for
cardiovascular (CV) disease and yet end up without a diagnosis but continued symptoms. Up
to 65% of women referred to coronary angiography have insignificant coronary artery stenosis,
as compared with 32% of men [1]. Nevertheless, these women have an increased risk of major
adverse CV events [2, 3]. Despite increasing interest in the combined presentation of angina
and no obstructive coronary artery disease (CAD), the underlying pathophysiologic mecha-
nisms remain unclear.
A large proportion of these women have non-endothelial or endothelial dependent coro-
nary microvascular dysfunction (CMD) [4, 5], which has been suggested to contribute to myo-
cardial abnormalities such as left ventricular (LV) hypertrophy and fibrosis leading to LV
diastolic dysfunction. Small echocardiographic studies in patients with microvascular angina
(n = 7 and n = 45) reported that LV diastolic function was impaired compared with asymp-
tomatic controls [6, 7]. A more recent cardiac magnetic resonance (CMR) study also showed
that women with signs and symptoms of ischemia in the absence of obstructive CAD (n = 20)
had abnormalities in diastolic function compared with age-matched controls (n = 15) [8].
However, larger studies assessing LV diastolic function in patients with angina and no obstruc-
tive CAD are lacking.
In view of this limited evidence, we investigated whether LV diastolic function assessed by
comprehensive transthoracic echocardiography (TTE) differed between women with angina
without obstructive CAD and an asymptomatic reference population with CV risk factors.
Methods
Population
Women (18–80 years) suspected of angina pectoris referred for a diagnostic invasive coronary
angiography (CAG) showing no significant stenosis (<50%) were systematically included in
this substudy of the iPOWER (improving diagnosis and treatment of women with angina pec-
toris and microvascular disease) study between March 2012 and September 2014. Recruitment
to the prospective iPOWER cohort was consecutive from all invasive centers in Eastern Den-
mark covering approximately 3 million inhabitants. In- and exclusion criteria are displayed in
Fig 1. Further details can be found in previous publications [4, 9]. Participants with no TTE
were excluded from this substudy.
For the reference group, we included women aged 40–80 years from a background popula-
tion with CV risk factors but no prior history of chest pain, dyspnea or cardiac disease, who
had participated in the community-based Copenhagen City Heart Study in 2012–14 [10].
Basic examination
For the women with angina, information regarding symptoms of angina was obtained and
classified as typical angina pectoris, atypical angina pectoris and non-cardiac chest pain [11].
Angina and no obstructive coronary artery disease
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transthoracic echocardiography.
Basic assessment in both the women with angina and the controls included clinical and demo-
graphic data. CV risk factors including age, body mass index (BMI), diabetes, hypertension,
smoking, and family history of CV disease was acquired from interviews undertaken by
trained health professionals and patient charts. Blood pressure was obtained at rest. Heart
rates were extracted from the continuous electrocardiogram (ECG) registered during the TTE
at resting conditions. Patients with angina had paused their beta-blocker and anti-hypertensive
medicine for 24 hours prior to the examination.
Echocardiographic examination
Both angina patients and controls underwent a standard resting TTE using GE Healthcare
Vivid E9 CV ultrasound system (GE Healthcare, Horten, Norway) with a 1.3–4.0 MHz trans-
ducer (GE Vivid 5S probe). Images were stored for off-line analysis (GE EchoPAC v.112, Nor-
way). A small team of investigators performed image acquisition. Two echocardiographers
performed all analyses blinded to baseline characteristics. We have reported good inter-
observer reproducibility for echocardiographic measurements between the two experts per-
forming the analyses for this current study [9].
Measurements of LV internal dimensions, LV mass index (LVMI) and left atrium volume
index (LAVI) determined by the ‘Volume Method of Discs’ were performed and calculated
according to European and American recommendations [12–14]. Relative wall thickness was
assessed as the posterior and the septum wall thickness in diastole divided by the left ventricu-
lar internal diameter in diastole: (IVSDd + LVPWd)/LVIDd.
Inclusion Criteria
(asertained from registry data)
Women aged 18-80 years with chest pain referred to cardiac centre and a 
coronary angiography with no signiﬁ cant stenotic lessions (≤50%) of  epi-
cardial vessels performed within 1 year of  inclusion
• No episodes of  chest pain within 6 months before inclusion
• Other cause of  chest pain deemed highly likely
• Left ventricular ejection fraction  <45%
• Signiﬁ cant valvular heart disease, congenital heart disease or 
cardiomyopathy
• Signiﬁ cant co-morbidity with <1 year expected survival
• Severe COPD with FEV1 <50% of  predicted
• Previous veriﬁ ed myocardial infarction or revascularization (PCI or 
CABG)
• Elevated cardiac biomarkers (high sensitive troponin >50 ng/L or 
4. generation troponin > 0.03 µg/L or CKMB > 4.0 µg/L)
• ECG with ST-segment elevation
• Pregnancy
• Travel distance (more than 3 hours)
• Language- or other barriers to giving informed consent
Exclusion Criteria
(asertained through patient 
records and patient contact)
Fig 1. Inclusion and exclusion criteria in the iPOWER study.
https://doi.org/10.1371/journal.pone.0216240.g001
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Echocardiographic parameters of diastolic function including the early (E) and late (A)
mitral inflow velocities, tissue Doppler early and late diastolic velocities in the lateral mitral
annulus (e’ and a’) and the E/A and e’/a’-ratios were used as surrogates of myocardial relaxa-
tion and LV compliance, the deceleration time as a surrogate of early LV stiffness and, E/e’ as a
surrogate estimate of LV filling pressures [14]. All measures were averaged over 3 heart cycles.
In case of fusion of the E and A or e’ and a’ waves (as for patients with atrial fibrillation at
examination), measurements were registered as missing.
LV filling pressure was categorized as normal or high by using a modified algorithm from
the recommendations of the American and European Societies of Echocardiography concern-
ing patients with preserved LV ejection fraction (LVEF), i.e. normal filling pressure if E/e’<8
or E/e’ 8–12 and LAVI<34 mL/m2, and high filling pressure if E/e’ 8–12 and LAVI>34 or E/
e’>12, respectively [14].
This study was performed in accordance with the Helsinki Declaration and was approved
by an institutional review board (the Danish Regional Committee on Biomedical Research
Ethics, H-3-2012-005). After receiving oral and written information about the study, all
patients gave written informed consent.
Statistical analyses
All echocardiographic parameters were reviewed for outliers by histogram plots and prespeci-
fied cut-offs.
Differences in distribution of CV risk factors, hemodynamic and echocardiographic vari-
ables between women with angina and asymptomatic controls were investigated with age-
adjusted linear regression analysis for continuous variables and logistic regression for dichoto-
mous variables. Multivariable regression analysis of echocardiographic parameters was used to
adjust for age, CV risk factors and medication. A subgroup analysis was performed comparing
only patients with either typical angina or dyspnea with controls. Normal distribution was
assessed graphically.
Confidence intervals (CI) refer to 95% intervals and a two-sided p-value below 0.05 was
considered significant. All analyses were performed using STATA/IC 13.1 (StataCorp LP, Col-
lege Station, TX, USA).
Results
Out of 3568 screened women with angina pectoris and no obstructive stenosis at CAG, 2159
met the iPOWER inclusion and exclusion criteria, 963 were reachable and wished to partici-
pate and 956 participants (99%) had TTE performed [4]. In total, 214 controls were included.
Baseline characteristics for both the patients with angina and the controls are displayed in
Table 1. A high prevalence of dyspnea (69%) was observed among patients with angina. The
patients with angina were slightly older than the controls (62.1 vs. 60.1 years). After adjustment
for age, the patients with angina had a higher burden of CV risk factors with the exception of
hypertension: 51% of both patients with angina and controls reported a history of hyperten-
sion. Patients with angina had more use of antihypertensive and other CV medication and
blood pressure was better controlled, despite the fact that patients with angina had paused
their beta-blocker and anti-hypertensive medicine for 24 hours prior to the examination.
Heart rate was higher in the patients with angina. After excluding participants receiving prior
beta-blocker treatment (n = 291) to avoid influence of withdrawal tachycardia, the difference
in heart rate between populations remained statistically significant (p = 0.002). There were 36
patients with permanent or paroxysmal atrial fibrillation. However, only 10 of these patients
had atrial fibrillation at time of examination.
Angina and no obstructive coronary artery disease
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The patients with angina had greater LV wall dimensions, a higher LVMI and larger LAVI
compared with the controls (Table 2). Apart from deceleration time and e’ that were similar
across the two groups, indices of LV diastolic function indicated a more impaired LV diastolic
function in the patients with angina. E/A-ratio and e’/a’ were reduced in the patients with
angina suggesting an impaired myocardial relaxation and reduced LV compliance. E/e’ was
increased indicating a higher LV filling pressure. Accordingly, a significantly larger proportion
of the patients with angina fulfilled guideline criteria for a high filling pressure (Table 2). For
patients with angina, dyspnea was reported in 74% of with high filling pressure compared with
62% in patients with normal filling pressure (p = 0.12).
Multivariable regression analyses were performed to examine whether CV risk factors and
medication and hemodynamic variables could explain differences between patients with
angina and controls in each of the measures of LV diastolic function. The estimated differences
between patients with angina and the controls in LV diastolic parameter values remained
highly significant after adjustment for heart rate, systolic blood pressure, atrial fibrillation and
CV risk factors (Table 3).
Across patient groups defined by symptom characteristics as typical angina, atypical angina
or non-cardiac chest pain, no differences in echocardiographic parameters were detected. LV
filling pressure showed no consistent associations with the burden of angina symptoms.
Table 1. Background characteristics of women with angina and no obstructive coronary artery disease and controls.
Women with angina
(n = 956)
Controls
(n = 214)
p-value�
Descriptive parameters †
Age (years), mean (SD) 62.1 (9.7) 60.1 (11.0) 0.008
Body Mass Index (kg/m2), mean (SD) 27.2 (5.4) 25.4 (4.4) <0.001
Hypertension, n (%) 484 (51) 109 (51) 0.35
Diabetes Mellitus, n (%) 126 (13) 5 (2) <0.001
Smoking (current), n (%) 152 (16) 25 (12) 0.037
Atrial fibrillation, n (%) 36 (4) 0 (0) ll NR
Dyspnea, n (%) 639 (69) 0 (0) ll NR
Hemodynamic parameters ‡
Heart rate (beats/min), mean (SD) 69.1 (10.7) 66.6 (9.8) 0.002
Systolic blood pressure (mmHg), mean (SD) 133.0 (21.8) 141.5 (21.7) <0.001
Diastolic blood pressure (mmHg), mean (SD) 74.3 (19.4) 80.3 (9.8) <0.001
Medication, §
Acetylsalicylic acid, n (%) 424 (45) 15 (7) <0.001
Beta-receptor blockers, n (%) 281 (30) 10 (5) <0.001
Cholesterol lowering drugs, n (%) 475 (50) 30 (15) <0.001
ACE-inhibitor, n (%) 139 (15) 13 (6) 0.002
Angiotensin-II-receptor blocker, n (%) 175 (19) 11 (5) <0.001
Calcium antagonist, n (%) 205 (22) 13 (6) <0.001
Thiazide, n (%) 146 (15) 16 (8) 0.008
Furosemide, n (%) 60 (6) 4 (2) 0.023
�p-value from age adjusted logistic or linear regression analysis. SD: Standard deviation.
†No more than 5 missing values
‡No more than 7 missing values
§No more than 26 missing values.
ll Controls with atrial fibrillation or dyspnea were excluded. NR: not relevant
https://doi.org/10.1371/journal.pone.0216240.t001
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However, patients with high filling pressure reported slightly more physical limitations and
lower angina stability (Table 4).
Above analyses only including patients with typical angina or patients with dyspnea yielded
similar results. Excluding patients with atrial fibrillation (n = 36) from the analysis also yielded
similar results.
Discussion
Higher LV filling pressures and impaired diastolic function were present in more women with
angina and no obstructive CAD compared with asymptomatic controls with cardiovascular
risk factors.
Women with angina had a higher CV risk factor burden, but the reference population also
had risk factors being from a normal background population. Notably, hypertension was
equally present in women with angina and controls. The blood pressure level was higher in
controls than in women with angina, which could be expected due to more aggressive treat-
ment in women referred for cardiac assessment. When adjusting for differences in CV risk fac-
tors, medication and hemodynamic variables between populations, the observed differences in
LV diastolic parameter values persisted suggesting that the impaired LV diastolic function in
patients with angina could not only be explained by a difference in CV risk factor profile.
Table 2. Echocardiographic parameters in women with angina and no obstructive coronary artery disease and
controls.
Women with angina (n = 956) Controls
(n = 214)
p-value�
Left ventricular and atrial dimensions †
LVIDd (cm), mean (SD) 4.66 (0.50) 4.58 (0.43) 0.019
LVPWd (cm), mean (SD) 0.83 (0.09) 0.76 (0.08) <0.001
IVSd (cm), mean (SD) 0.86 (0.09) 0.81 (0.09) <0.001
LVMI g/m2), mean (SD) 71.8 (13.9) 65.7 (12.3) <0.001
LAVI (ml/m2), mean (SD) 29.5 (7.9) 27.0 (5.7) <0.001
Left ventricular ejection fraction (%), mean (SD) 58.6 (6.0) 57.6 (5.4) 0.026
Relative wall thickness (cm2/cm), mean (SD) 0.37 (0.05) 0.35 (0.04) <0.001
Left ventricular diastolic function ‡
E (cm/s), mean (SD) 73.3 (16.3) 68.4 (14.4) <0.001
A (cm/s), mean (SD) 73.0 (16.8) 62.2 (17.4) <0.001
Deceleration time (ms), mean (SD) 183 (32) 179 (30) 0.20
E/A ratio, mean (SD) 1.03 (0.30) 1.18 (0.40) <0.001
e’(cm/s), mean (SD) 10.0 (2.8) 10.6 (3.3) 0.20
a’ (cm/s), mean (SD) 10.5 (2.6) 9.0 (2.6) <0.001
E/e’ ratio, mean (SD) 7.9 (2.7) 7.0 (2.2) <0.001
e’ /a’, mean (SD) 1.03 (0.44) 1.29 (0.61) <0.001
Estimated high filling pressure ll, n (%) 150 (17) 13 (6) 0.001
�p-value from age adjusted logistic or linear regression analysis. SD: Standard deviation, LVIDd: Left ventricular
internal diameter in diastole, LVPWd: Posterior wall thickness in diastole, IVSd: Septum wall thickness in diastole,
LVMI: Left ventricular mass index, LAVI: Left atrium volume index.
†No more than 57 missing values
‡No more than 65 missing values
ll Filling pressure was estimated as normal if E/e’ lat<8 or E/e’ lat is between 8–12 and LAVI<34 mL/m2 and high if
E/e’ is between 8–12 and LAVI>34 or E/e’>12.
https://doi.org/10.1371/journal.pone.0216240.t002
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Differences in echocardiographic parameters between symptomatic patients and the controls
are not likely to have clinical implications because the differences are minor and therefore can-
not be used in a diagnostic setting. However, this is a group of patients that is at the moment
left undiagnosed since we do not know the pathophysiology behind their symptoms. This
study showed that these patients had a slightly impaired LV diastolic function compared with
a reference population. Typical angina symptoms or burden of symptoms could not indicate
which patients had high filling pressure estimated by echocardiography. However, symptoms
are very subjective and difficult to assess. The prevalence of typical angina in our population
Table 3. Estimated differences in diastolic and systolic parameters between angina patients and controls from multivariable adjusted regression analyses.
β (95% CI), adjusted for age only β (95% CI), multivariable adjusted regression p-value�
Left ventricular mass index (g/m2) 5.73 (3.71; 7.75) 5.54 (3.24; 7.84) <0.001
Left atrium volume index (mL/m2) 2.34 (1.23; 3.45) 1.85 (0.62; 3.07) 0.003
E (cm/s) 5.32 (2.94; 7.70) 3.83 (1.09; 6.57) 0.006
E/A ratio -0.13 (-0.17; -0.08) -0.12 (-0.17; -0.07) <0.001
E/e’ 0.68 (0.30; 1.05) 0.50 (0.07; 0.92) 0.02
e’ /a’ -0.22 (-0.28; -0.15) -0.19 (-0.26; -0.12) <0.001
Odds ratio (CI), adjusted for age only Odds ratio (CI), multivariable adjusted regression
High filling pressure ll 2.90 (1.58; 5.34) 2.70 (1.34; 5.47) 0.006
�p-value from separate multivariable logistic or linear regression with each echocardiographic parameters as outcome and a variable indicating population—women
with angina/asymptomatic reference population—as an independent variable; adjusted for age, cardiovascular (CV) risk factors, heart rate, systolic and diastolic blood
pressure, and CV medication from Table 1 (Echocardiographic parameter = β�”women with angina/controls”+β1�age+β2�”CV risk factors”+β3�”hemodynamic
parameters”+β4�”CV medication”). β is the regression coefficient.
Example: The interpretation of the beta-coefficient is that a patient with angina had 5.54 greater LVMI than a control after adjustment for differences between
populations. ll Filling pressure was estimated as normal if E/e’<8 or E/e’ is between 8–12 and LAVI<34 mL/m2 and high if E/e’ is between 8–12 and LAVI>34 or E/
e’>12. CI: Confidence interval
https://doi.org/10.1371/journal.pone.0216240.t003
Table 4. Burden of angina symptoms distributed between normal and high filling pressure.
Normal filling pressure
(n = 753, 83%)
High filling pressure (n = 150, 17%) p-value�
Symptom characteristics for classic chest pain classification
Typical angina, n (%) 158 (21) 32 (21) 0.97��
Atypical angina, n (%) 354 (47) 69 (46)
Non-cardiac chest pain, n (%) 241 (32) 49 (33)
Rose’s angina classification
Severe definite angina, n (%) 126 (17) 30 (21) 0.34��
Non-severe definite angina, n (%) 195 (27) 31 (22)
Non-definite angina, n (%) 404 (56) 82 (57)
Symptom burden by Seattle Angina Questionnaire †
Physical limitation, mean (SD) 75 (23) 69 (22) 0.05
Angina stability, mean (SD) 64 (29) 60 (27) 0.03
Angina frequency, mean (SD) 76 (23) 74 (23) 0.22
Treatment Satisfaction, mean (SD) 65 (25) 69 (24) 0.40
Perception/Quality of Life, mean (SD) 50 (26) 49 (29) 0.11
�p-value from age-adjusted linear regression.
��p-value from chi-squared analysis.
†Low score indicating higher symptom burden.
https://doi.org/10.1371/journal.pone.0216240.t004
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was identical to that of women with obstructive CAD from the CONFIRM registry (coronary
CT angiography evaluation for clinical outcomes: an international multicenter registry) [15].
When comparing only patients with typical angina with the controls the same conclusions
were reached.
Only a handful of previous small studies have addressed diastolic function in women with
angina and no obstructive CAD. The conclusion from these is in concordance with our results
supporting that women with angina have a more impaired LV diastolic dysfunction compared
with controls [6–8]. It has recently been speculated that CMD through induction of transient
myocardial ischemia and fibrosis leads to impairment of LV diastolic function, i.e. that there is
a link between angina with no obstructive CAD and heart failure with preserved LVEF
(HFpEF) [16]. In fact, prevalence of CMD is high in both patients with HFpEF and patients
with angina and no obstructive CAD [4, 5, 17, 18]. In this current population of women with
angina we previously found that the prevalence of CMD assessed by transthoracic echocardi-
ography was 26% [4]. Furthermore, many of the women in this study also had dyspnea
(~70%). In a recent PET study of patients with angina and no obstructive CAD (n = 201) a
link between CMD and diastolic dysfunction was found [19]. However, we have previously
reported no association between CMD assessed by TTE and diastolic function (n = 956) in this
population [20].
Another possible explanation for the greater LVMI and more diastolic impairment could
be that women with no obstructive CAD have a higher degree of myocardial fibrosis due to the
higher CV risk factor burden. However, in our study the women with angina and the controls
had a similar prevalence of hypertension [21], which is the main contributor to the develop-
ment of myocardial fibrosis and adverse cardiac remodeling. Furthermore, differences in LV
diastolic function were unaffected by adjustment for differences in CV risk factors indicating
that the differences in left ventricular diastolic function between angina patients and controls
is independent of risk factor burden.
Strengths and limitations
The Strengths of the study were the size of the study populations and the consecutive
recruitment of angina patients making results generalizable to larger clinical populations.
The women that were invited and did not wish to participate had a higher prevalence of CV
risk factors, which could only underestimate the prevalence of left ventricular diastolic dys-
function [4]. The control group in this study was representative of a background population
and thus had a high prevalence of risk factors, including hypertension, making this control
group more comparable to the angina patients. This contrasts with other studies that have
used healthy women with low risk factor burden as reference [7, 8]. Controls were, however,
slightly younger and leaner than the patients with angina, which is why all statistical com-
parisons were age-adjusted. Echocardiographic parameters were analyzed with a good
inter-analyzer reproducibility as documented in a previous publication [9]. The 2009 guide-
line definition for LV diastolic dysfunction was utilized. The definition was revised in 2016
recommendations. However, because this study was commenced in 2012 not all parameters
for diastolic function used in the recommendations for 2016 was measured [14, 22].
Although, many parameters of diastolic function were more impaired in the women with
angina there was no difference in e’ between groups. Lastly, the present study offered no
mechanistic insight and we cannot exclude that the differences between the patients with
angina and the controls could in part be due to unmeasured confounding factors such as
obstructive sleep apnea, insulin resistance, epicardial fat, and several inflammatory
conditions.
Angina and no obstructive coronary artery disease
PLOS ONE | https://doi.org/10.1371/journal.pone.0216240 May 23, 2019 8 / 11
Conclusion
Among women with angina and no obstructive CAD, estimated high filling pressure and
parameters of impaired diastolic function were more prevalent except for suggesting a poten-
tial link between angina with no obstructive CAD and diastolic dysfunction. However, the
common denominators are unknown
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